- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00604045
DoD PTSD November 13 - Information Processing Modification in the Treatment of PTSD
February 11, 2014 updated by: Nader Amir, San Diego State University
Information Processing Modification in the Treatment of PTSD
The purpose of this study is to determine whether a computerized intervention designed to change the nature of attention biases will be effective in reducing the symptoms of post traumatic stress disorder (PTSD) in American combat veterans returning from the wars in Afghanistan and Iraq.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
Thirty percent of returning veterans present with mental health problems with Posttraumatic stress disorder (PTSD) as the most common problem in this group (52% of overall diagnoses).
This translates into PTSD prevalence rates of 12% in Afghani veterans and 19% for Iraqi veterans, rates that are two to three times higher than the overall lifetime prevalence rate in the general population (8%).
Moreover, 70% have not received any mental health services.
Thus the majority are not receiving any help.
Those with PTSD are likely to experience problems across several life domains including higher rates of divorce, problems raising children, and engaging in domestic violence.
They are also more likely to suffer from other mental health problems including depression, substance abuse, and generalized anxiety disorder.
Forty four percent of individuals with PTSD do not respond to psychosocial and pharmacological treatments.
Thus, there is a clear need to develop highly effective and efficient treatments for PTSD.
Researchers have established a relationship between PTSD and difficulty disengaging attention from threat relevant information.
This knowledge; however, has not been translated into more effective treatments for this disorder.
This five-year proposal aims to test a computerized treatment for PTSD in a double-blind, placebo-controlled study that would bridge research on attention bias and treatment development.
Those in the active condition will receive a computer-delivered attention modification program (AMP) designed to enhance attention disengagement from threatening stimuli.
The AMP protocol includes six weeks of biweekly sessions in which participants see 240 trials consisting of the various combinations of probe type (E or F), probe position (top or bottom), and word type (Neutral or Trauma).
Of the 240 trials, 48 include only neutral words: 2 (probe type) X 2 (probe position) X 12 (word pairs).
The remaining 192 trials include one neutral word and one trauma word: 2 (probe type) X 2 (probe position) X 2 (repetitions) X 24 (word pairs).
On trials where participants see one neutral word and one trauma word (i.e., 80% of the trials), the probe always follows the neutral word.
Thus, although there is no specific instruction to direct attention away from threat word, on 80% of the trials the position of the threat word indicates the position of the probe (i.e., in the location opposite the threat word).
The placebo condition (PC) will be identical to the AMP condition except that during the presentation of threat/neutral word pairs, the probe will appear with equal frequency in the position of threat and neutral words.
Thus, neither threat nor neutral words have signal value.
We have used this intervention to successfully establish a pattern of enhanced attention disengagement to threat words in 3 studies.
We present the results from 3 clinical trials demonstrating the efficacy of attention modification programs (AMP) in ameliorating symptoms of anxiety.
Specifically, we report results from studies of individuals with generalized social phobia (GSP; n=53) and generalized anxiety disorder (GAD; n=24) demonstrating the effectiveness of the procedures described in this proposal.
In brief, our intervention was effective in: a) changing biased attention, b) reducing clinical symptoms of anxiety, c) maintaining its effects in up to one year follow-up.
This efficient and efficacious technique for changing attention bias in anxiety can provide a low cost, easy to administer treatment that is grounded in basic cognitive science that may help reduce suffering in individuals with anxiety.
The goal of the current proposal is to extend these findings to the highly related disorder of PTSD, and to examine the generalizability of the results to individuals with comorbid conditions.
In the current proposal we will test two hypotheses: 1) Individuals with PTSD completing the AMP will show a larger reduction in their attention bias to threat compared to the placebo group, 2) Individuals with PTSD completing AMP will show a larger reduction in anxiety symptoms compared to the placebo group.
Study Type
Interventional
Enrollment (Actual)
25
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
San Diego, California, United States, 92120
- Center for Understanding and Treating Anxiety
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Primary DSM-IV-TR Axis I diagnosis of post-traumatic stress disorder
- Combat veteran from Iraq and/or Afghanistan
Exclusion Criteria:
- No change in medication type or dose during the twelve weeks prior to treatment
- No current psychotherapy
- No evidence of suicidal intent
- No evidence of current substance dependence in the past 6 months
- No evidence of current or past schizophrenia, bipolar disorder, or organic mental disorder
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: 1 Attention Bias Modification (ABM)
The ABM comprised a probe detection paradigm described above, modified to facilitate the allocation of attention away from threatening material.
In this task, the probe always replaced the neutral word.
Stimuli comprised a different set of 12 threat-neutral word pairs different than those used in the attention bias assessment.
Participants completed 288 training trials: 2 (probe type) x 2 (probe location) x 2 (threat location) x 12 (threat-neutral word pairs) x 3 (repetition).
Thus, although there were no explicit instructions to direct attention away from threat words, on all trials, the position of the neutral word indicated the position of the probe.
|
The ABM comprised a probe detection paradigm described above, modified to facilitate the allocation of attention away from threatening material.
In this task, the probe always replaced the neutral word.
Stimuli comprised a different set of 12 threat-neutral word pairs different than those used in the attention bias assessment.
Participants completed 288 training trials: 2 (probe type) x 2 (probe location) x 2 (threat location) x 12 (threat-neutral word pairs) x 3 (repetition).
Thus, although there were no explicit instructions to direct attention away from threat words, on all trials, the position of the neutral word indicated the position of the probe.
|
Placebo Comparator: 2 Attention Control Condition (ACC)
The ACC condition was identical to the ABM procedure with the exception that the probe appeared with equal frequency in the position of the threat and neutral words, such that attention was neither trained towards nor away from threat.
|
The ACC condition was identical to the ABM procedure with the exception that the probe appeared with equal frequency in the position of the threat and neutral words, such that attention was neither trained towards nor away from threat.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Post-Traumatic Stress Disorder Checklist-Military Version (PCL-M)
Time Frame: Pre-Treatment, Post-Treatment (after 4 weeks of treatment)
|
The PCL-5 is a 20-item self-report measure that assesses the 20 DSM-5 symptoms of PTSD.
Scores range from 0 to 80, with higher scores indicating more severe symptoms.
|
Pre-Treatment, Post-Treatment (after 4 weeks of treatment)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Nader Amir, PhD, San Diego State University
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2009
Primary Completion (Actual)
May 1, 2012
Study Completion (Actual)
May 1, 2012
Study Registration Dates
First Submitted
January 16, 2008
First Submitted That Met QC Criteria
January 28, 2008
First Posted (Estimate)
January 29, 2008
Study Record Updates
Last Update Posted (Estimate)
March 28, 2014
Last Update Submitted That Met QC Criteria
February 11, 2014
Last Verified
January 1, 2008
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PT075321 (Other Identifier: Department of Defense)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress Disorders, Post-Traumatic
-
University of California, Los AngelesDefense Advanced Research Projects Agency; Defense Group, Inc.CompletedPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder, ChronicUnited States
-
Weill Medical College of Cornell UniversityCompletedPost-traumatic Stress Disorder | Complex Post-Traumatic Stress DisorderUnited States
-
Oregon Health and Science UniversityNational Center for Complementary and Integrative Health (NCCIH); Oregon Clinical...CompletedPost-Traumatic Stress DisordersUnited States
-
US Department of Veterans AffairsEmory UniversityWithdrawnPost-Traumatic Stress Disorders
-
University of KonstanzGerman Research Foundation; NGO vivo e.V.; GTZ-German Technical Cooperation,... and other collaboratorsCompletedPost-Traumatic Stress DisordersSri Lanka
-
University Hospital, ToulouseCompletedPost-traumatic StressFrance
-
University of California, Los AngelesRecruitingPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder in ChildrenUnited States
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPost-Traumatic Stress Disorder in Children | Post-Traumatic Stress Disorder in AdolescenceUnited States
-
University Hospital, LilleNot yet recruiting
-
Steinn SteingrimssonRecruiting
Clinical Trials on Attention Bias Modification (ABM)
-
University of Texas at TylerPsi Chi; Sarah Sass, PhDRecruiting
-
Tel Aviv UniversityCompleted
-
Tel Aviv UniversityCompletedSocial Anxiety DisorderIsrael
-
Sorlandet Hospital HFUniversity of Oslo; Karolinska Institutet; University of Oxford; The Hospital of... and other collaboratorsCompleted
-
University of California, Los AngelesCompleted
-
Tel Aviv UniversityCompleted
-
San Diego State UniversityCompletedStress Disorders, Post-traumaticUnited States
-
Hebrew University of JerusalemIsrael Science FoundationCompleted
-
Research Foundation for Mental Hygiene, Inc.Completed
-
University of Texas at AustinArcade TherapeuticsNot yet recruiting